CDH11 Regulates Adhesion and Transcellular Migration of Tongue Squamous Cell Carcinoma

References

• Mantsopoulos K, Psychogios G, Künzel J, et al. Primary surgical therapy for locally limited oral tongue cancer. Biomed Res Int. 2014;2014:738716. doi:10.1155/2014/738716
   PubMed Web of Science ®Google Scholar
• Annertz K, Anderson H, Biörklund A, et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer. 2002;101(1):95–99. doi:10.1002/ijc.10577
   PubMed Web of Science ®Google Scholar
• Rusthoven K, Ballonoff A, Raben D, et al. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer. 2008;112(2):345–351. doi:10.1002/cncr.23183
   PubMed Web of Science ®Google Scholar
• Marie PJ, Haÿ E, Modrowski D, et al. Cadherin-mediated cell-cell adhesion and signaling in the skeleton. Calcif Tissue Int. 2014;94(1):46–54. doi:10.1007/s00223-013-9733-7
   PubMed Web of Science ®Google Scholar
• Seong E, Yuan L, Arikkath J. Cadherins and catenins in dendrite and synapse morphogenesis. Cell Adh Migr. 2015;9(3):202–213. doi:10.4161/19336918.2014.994919
   PubMed Web of Science ®Google Scholar
• Tepass U, Truong K, Godt D, et al. Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol. 2000;1(2):91–100. doi:10.1038/35040042
   PubMed Web of Science ®Google Scholar
• Afrem MC, Mărgăritescu C, Crăiţoiu MM, et al. The immunohistochemical investigations of cadherin “switch” during epithelial-mesenchymal transition of tongue squamous cell carcinoma. Rom J Morphol Embryol. 2014;55(3 Suppl):1049–1056.
   PubMed Web of Science ®Google Scholar
• Zhang H, Tang Z, Deng C, et al. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma. Oral Dis. 2017;23(2):255–264. doi:10.1111/odi.12608
   PubMed Web of Science ®Google Scholar
• Loh CY, Chai JY, Tang TF, et al. The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8(10):1118. doi:10.3390/cells8101118
   PubMed Web of Science ®Google Scholar
• Rosso M, Majem B, Devis L, et al. E-cadherin: a determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness. PLoS One. 2017;12(9):e0184439. doi:10.1371/journal.pone.0184439
   PubMed Web of Science ®Google Scholar
• Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68(10):3645–3654. doi:10.1158/0008-5472.CAN-07-2938
   PubMed Web of Science ®Google Scholar
• Hoque Apu E, Akram SU, Rissanen J, et al. Desmoglein 3 - influence on oral carcinoma cell migration and invasion. Exp Cell Res. 2018;370(2):353–364. doi:10.1016/j.yexcr.2018.06.037
   PubMed Web of Science ®Google Scholar
• Moftah H, Dias K, Apu EH, et al. Desmoglein 3 regulates membrane trafficking of cadherins, an implication in cell-cell adhesion. Cell Adh Migr. 2017;11(3):211–232. doi:10.1080/19336918.2016.1195942
   PubMed Web of Science ®Google Scholar
• Satriyo PB, Bamodu OA, Chen JH, et al. Cadherin 11 inhibition downregulates β-catenin, deactivates the canonical WNT signalling pathway and suppresses the cancer stem cell-like phenotype of triple negative breast cancer. J Clin Med. 2019;8(2):148. doi:10.3390/jcm8020148
   PubMed Web of Science ®Google Scholar
• Geletu M, Arulanandam R, Chevalier S, et al. Classical cadherins control survival through the gp130/Stat3 axis. Biochim Biophys Acta. 2013;1833(8):1947–1959. doi:10.1016/j.bbamcr.2013.03.014
   PubMed Web of Science ®Google Scholar
• Simonneau L, Kitagawa M, Suzuki S, et al. Cadherin 11 expression marks the mesenchymal phenotype: towards new functions for cadherins? Cell Adhes Commun. 1995;3(2):115–130. doi:10.3109/15419069509081281
   PubMed Web of Science ®Google Scholar
• Hoffmann I, Balling R. Cloning and expression analysis of a novel mesodermally expressed cadherin. Dev Biol. 1995;169(1):337–346. doi:10.1006/dbio.1995.1148
   PubMed Web of Science ®Google Scholar
• Huang CF, Lira C, Chu K, et al. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res. 2010;70(11):4580–4589. doi:10.1158/0008-5472.CAN-09-3016
   PubMed Web of Science ®Google Scholar
• Chu K, Cheng CJ, Ye X, et al. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res. 2008;6(8):1259–1267. doi:10.1158/1541-7786.MCR-08-0077
   PubMed Web of Science ®Google Scholar
• Li Z, Zhou Z, Donahue HJ. Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin Exp Metastasis. 2008;25(3):265–272. doi:10.1007/s10585-007-9140-4
   PubMed Web of Science ®Google Scholar
• Pishvaian MJ, Feltes CM, Thompson P, et al. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res. 1999;59(4):947–952.
   PubMed Web of Science ®Google Scholar
• Kashima T, Kawaguchi J, Takeshita S, et al. Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis. Am J Pathol. 1999;155(5):1549–1555. doi:10.1016/S0002-9440(10)65471-5
   PubMed Web of Science ®Google Scholar
• Carmona FJ, Villanueva A, Vidal A, et al. Epigenetic disruption of cadherin-11 in human cancer metastasis. J Pathol. 2012;228(2):230–240. doi:10.1002/path.4011
   PubMed Web of Science ®Google Scholar
• Piao S, Inglehart RC, Scanlon CS, et al. CDH11 inhibits proliferation and invasion in head and neck cancer. J Oral Pathol Med. 2017;46(2):89–97. doi:10.1111/jop.12471
   PubMed Web of Science ®Google Scholar
• Gan RH, Wei H, Xie J, et al. Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion. Cell Cycle. 2018;17(2):216–224. doi:10.1080/15384101.2017.1395534
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.31937
   PubMed Web of Science ®Google Scholar
• Massano J, Regateiro FS, Januário G, et al. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(1):67–76. doi:10.1016/j.tripleo.2005.07.038
   PubMed Web of Science ®Google Scholar
• Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359(11):1116–1127. doi:10.1056/NEJMoa0802656
   PubMed Web of Science ®Google Scholar
• Marchong MN, Yurkowski C, Ma C, et al. Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death. PLoS Genet. 2010;6(4):e1000923. doi:10.1371/journal.pgen.1000923
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang C, Zhang M, et al. Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration. Oncotarget. 2017;8(64):107477–107491. doi:10.18632/oncotarget.22491
   PubMedGoogle Scholar
• Bello SM, Millo H, Rajebhosale M, Price SR. Catenin-dependent cadherin function drives divisional segregation of spinal motor neurons. J Neurosci. 2012;32(2):490–505. doi:10.1523/JNEUROSCI.4382-11.2012
   PubMed Web of Science ®Google Scholar